Company Filing History:
Years Active: 1998-2000
Title: Berthold Henglein: Innovator in Cellular Proliferation Detection
Introduction
Berthold Henglein is a notable inventor based in Paris, France. He has made significant contributions to the field of molecular biology, particularly in the detection of cellular proliferation. With a total of 2 patents, his work has implications for cancer research and diagnostics.
Latest Patents
Henglein's latest patents include a groundbreaking invention related to a nucleotide sequence encoding human cyclin A. This invention is directed towards a DNA sequence coding for human cyclin A and focuses on antibodies that bind to this protein. These antibodies are useful in detecting cellular proliferation, which is crucial for diagnosing conditions such as cancer. The invention highlights the importance of human cyclin A as a site for the integration of the hepatitis B virus, which is associated with hepatocellular carcinoma. By utilizing these antibodies, early detection of cell proliferation and tumorigenesis can be achieved, allowing for timely treatment options.
Career Highlights
Henglein is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he continues to advance research in his field. His work has garnered attention for its potential to improve diagnostic methods and therapeutic strategies in oncology.
Collaborations
Some of his notable coworkers include Christian Brechot and Jian Wang, who have contributed to the collaborative efforts in research and development within the institution.
Conclusion
Berthold Henglein's innovative work in the detection of cellular proliferation through his patents has the potential to significantly impact cancer diagnostics and treatment. His contributions to molecular biology continue to pave the way for advancements in medical research.